Lifeline Pacing Lead Model 465-01
by Intermedics, Inc. 510(k)
Active
510(k) K781497
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK781497 | Date1 Feb 1979 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- DTB
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3680
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 20 Sep 2026
The Lifeline Pacing Lead Model 465-01 is a Permanent Pacemaker Electrode, designed to deliver electrical impulses to the heart for pacing purposes. This device is intended for implantation within the cardiovascular system to regulate abnormal heart rhythms by stimulating cardiac contraction. It features a lead system that connects to a pacemaker, ensuring precise and reliable pacing support for patients with bradycardia or other conduction disorders.
This device is supplied sterile and intended for single-use implantation in a clinical setting. It is classified as a Class III medical device under FDA regulations (870.3680) and has received FDA 510(k) clearance (K781497) under the Traditional review pathway. The lead is compatible with MRI environments under specific conditions, as outlined in its labeling. Storage requires adherence to manufacturer guidelines to maintain sterility and functionality prior to use.
Other devices from Intermedics, Inc.
Questions
AI-generated answers, 20 Sep 2026
What is the primary purpose of the Lifeline Pacing Lead Model 465-01 in clinical practice?
The Lifeline Pacing Lead Model 465-01 is designed to deliver electrical impulses to the heart to regulate abnormal heart rhythms, specifically for patients with bradycardia or conduction disorders. It connects to a pacemaker to provide precise and reliable pacing support, ensuring consistent cardiac contraction when the heart’s natural rhythm is compromised.
Is this device intended for reuse, or is it meant to be used only once after implantation?
The Lifeline Pacing Lead Model 465-01 is supplied sterile and explicitly intended for single-use implantation in a clinical setting. It is not designed for reuse, as its sterile packaging and one-time-use labeling reflect standard practices for implanted cardiovascular devices to ensure patient safety and sterility.
How should the device be stored to maintain its sterility and functionality before use?
Storage must follow the manufacturer’s guidelines to preserve sterility and functionality. Since it is supplied sterile and intended for single-use, it should remain in its original, unopened packaging until immediately before implantation. Exposure to moisture, extreme temperatures, or contamination could compromise its integrity, so adherence to Intermedics’ specific storage instructions is critical.
Can this pacing lead be used in patients who require MRI scans, and if so, under what conditions?
Yes, the Lifeline Pacing Lead Model 465-01 is compatible with MRI environments under specific conditions, as outlined in its labeling. However, the exact parameters (e.g., MRI strength, safety protocols) must be followed to avoid risks like lead displacement or interference. Always refer to the device’s labeling or consult Intermedics’ instructions for MRI-compatible use.
What regulatory pathway was followed for FDA clearance of this device, and what does that mean for its safety and equivalence?
The Lifeline Pacing Lead Model 465-01 received FDA 510(k) clearance under the Traditional review pathway, with a decision of *Substantially Equivalent* (SESE) to a predicate device. This means the FDA determined it has the same intended use and technological characteristics as a previously cleared device, ensuring it meets safety and effectiveness standards. The clearance was granted in 1979, though subsequent manufacturing updates may apply.